Mariam Adeleke

Mariam Adeleke

Auto-generated profile, based on publicly available information

Mariam Adeleke

Department of Statistical Science, University College London, London, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2025 in Age and Ageing
Verified
Journal Article
Open access
SASarah Amador
Sarah Amador
GLGill Livingston
Gill Livingston
MAMariam Adeleke
Mariam Adeleke
JBJulie Barber
Julie Barber
LWLucy Webster
Lucy Webster
PRPenny Rapaport
Penny Rapaport
Introduction: DREAMS-START is a multicomponent intervention targeting sleep disturbance in people with dementia. To enhance understanding of the DREAMS-START randomised controlled trial, which showed improved sleep in the intervention compared to the control arm, we conducted a process evaluation exploring (i) DREAMS-START delivery, (ii) behaviour change mechanisms and (iii) contextual factors impacting outcomes. Methods: Mixed-methods design. We measured intervention adherence, fidelity and additional therapeutic process measures. We interviewed a sub-sample of intervention arm family carers and facilitators delivering DREAMS-START. We analysed data thematically guided by a prespecified theory of change logic model informed by the Theoretical Domains Framework. We measured movement using an actigraph worn by the person with dementia at baseline and at four- and eight-month follow-ups to explore potential mechanisms of action. Results: Attendance was good (82.8% attended ≥4/6 sessions). Mean fidelity score (95.4%; SD 0.08) and median score for all four process measures assessed (5/5; IQR 5–5) were high. We interviewed 43/188 family carers and 9/49 DREAMS-START facilitators. We identified three overarching themes aligned with our model: (i) knowledge and facilitation enable behaviour change, (ii) increasing sleep pressure and developing skills to manage sleep disturbances and (iii) Establishing a routine and sense of control. We were unable to collect sufficient data for pre-specified actigraphy analyses. Conclusion: Despite competing demands, carers attended DREAMS-START. It promoted behaviour change through supportive in-session reflection, increasing carer knowledge and skills. This was embedded between sessions and actions were positively reinforced as carers experienced changes. Results will inform future implementation in clinical services.

28 July 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
Duvern RamiahDuvern Ramiah
Duvern Ramiah
SNSonwabile Ngcezu
Sonwabile Ngcezu
OAOluwatosin Ayeni
Oluwatosin Ayeni
OAOkechinyere Achilonu
Okechinyere Achilonu
MAMariam Adeleke
Mariam Adeleke
DMDaniel Mmereki
Daniel Mmereki
Background: Access to timely radiotherapy in resource-constrained environments, particularly low- and middle-income countries (LMIC), is hampered by infrastructure constraints, workforce shortages, and a rising cancer burden. Remote radiotherapy planning (treatment planning as a service [TPaaS]) has the potential to enhance workflow efficiency, reduce wait times, and expand access to treatment. However, its integration and feasibility in LMIC public health systems remain underexplored. Objective: This study evaluates the feasibility and initial effectiveness of remote radiotherapy planning using the Varian Eclipse system integrated with Elekta Versa HD linear accelerators (LINACs) at the busiest public hospital in South Africa. The primary goal is to determine whether remote planning can maintain plan quality while enhancing efficiency and minimizing treatment delays. Methods: A prospective, single-site, pilot study is being conducted at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in 2 phases. Phase 1 (feasibility) encompasses system commissioning, including beam modeling, computed tomography (CT)-to-electron density calibration, multileaf collimator (MLC) optimization, and dose calculations using the anisotropic analytical algorithm. System performance is validated through gamma index analysis (≥95% pass at 3%/3 mm). Interoperability and workflow readiness are assessed using simulated clinical scenarios and time integration steps. Phase 2 (effectiveness/impact) evaluates operational outcomes in 100 screened adult patients (≥18 years) with cervical, breast, prostate, head and neck, or rectal cancers requiring curative radiotherapy. Patients are grouped by cancer type (25 per group). Time to treatment, plan quality, and system efficiency will be compared with historical in-person planning data. Key workflow metrics include dates of first consultation, CT simulation, planning initiation, plan approval, quality assurance, and treatment start and completion. Results: The study commenced enrollment in November 2023, with completion anticipated by mid-2025. As of July 2024, approximately 44 patients were screened and are anticipated to complete the remote planning. Initial findings show successful MLC transmission and dosimetric leaf gap optimization through iterative testing. Gamma pass rates exceeded 90% on both clinical and test servers, demonstrating initial accuracy. Results, including planning timelines, quality assurance outcomes, and system performance, will be available following comprehensive analysis in the third quarter of 2025. Preliminary findings indicate effective integration of remote planning in a resource-constrained public health sector setting. Conclusions: This study shows that remote radiotherapy planning is feasible and might improve cancer treatment in LMIC. The integration of commercially available systems, such as TPaaS, was successfully achieved without compromising dosimetric quality and ensured workflow continuity. Remote planning could serve as an effective tool to reduce treatment delays and enhance resource utilization in oncology units facing high demand. These findings offer valuable insights into technical integration, quality planning, and workflow outcomes, which can inform the future implementation of effective strategies in resource-constrained settings. International Registered Report Identifier (IRRID): DERR1-10.2196/60131

1 January 2025 in Parkinson's Disease
Verified
Journal Article
Open access
TRTasmin Rookes
Tasmin Rookes
MAMegan Armstrong
Megan Armstrong
KWKate Walters
Kate Walters
JRJoy Read
Joy Read
ECElizabeth Chesterman
Elizabeth Chesterman
ASAnette-Eleonore Schrag
Anette-Eleonore Schrag
Managing Parkinson’s disease (PD) symptoms can be challenging due to multiple factors, including complex symptoms, which are often reported late, and a lack of resources, resulting in worse outcomes. Self‐management of PD symptoms is a priority for patients, their carers, healthcare staff and systems. However, there is no effective comprehensive self‐management intervention for use in the United Kingdom to support people with PD to self‐manage problematic symptoms. We have developed a facilitated self‐management toolkit through literature reviews and co‐design workshops. We conducted a single‐group, pre–post feasibility study to evaluate the feasibility and acceptability of this toolkit, ahead of a randomised controlled trial (RCT). We assessed the feasibility of the study by measuring recruitment rate, retention rate, data completion, outcome measures and serious adverse events. In addition, we collected fidelity data to ensure the intervention was delivered as designed. For acceptability, we measured participants’ engagement through attendance at sessions, as well as through a feedback survey completed by participants at follow‐up. In a subgroup of participants, we conducted semistructured interviews to gain feedback on what participants thought was good and what could be improved with the intervention, as well as how acceptable the trial procedures were. All quantitative data were summarised descriptively, and qualitative data were analysed using codebook thematic analysis. We successfully recruited the target population within a predefined timeline, maintained intervention engagement and completed sufficient follow‐up, with limited missing data and no intervention‐related serious adverse events. The intervention was delivered with 93% fidelity, and 89% of participants were engaged. Participants found the supporter sessions most helpful, followed by information pages, and setting person‐centred goals. Having all their PD information in one place was seen as valuable, as well as talking through their challenges and problem‐solving how to overcome them. The toolkit is now being tested in a national RCT. Trial Registration: ISRCTN registry: ISRCTN92831552

26 May 2025 in JMIR Preprints
Verified
Preprint
Open access
BDBelinda Jayne Durey
Belinda Jayne Durey
Alison M. CoatesAlison M. Coates
Alison M. Coates
KDKade Davison
Kade Davison
BTBrett Tarca
Brett Tarca
JMJessica Mok
Jessica Mok
DMDaniel S Martin
Daniel S Martin
BACKGROUND Obesity affects over one billion people globally and is a leading contributor to chronic disease. For those with clinically severe obesity, metabolic and bariatric surgery (MBS) is the most effective intervention for long-term weight loss. However, surgery is often delayed due to systemic barriers, during which time patients may experience further health decline. Low cardiorespiratory fitness is a known risk factor for perioperative complications, prompting recommendations for prehabilitation to target readiness for surgery. Despite this, few patients meet physical activity guidelines, and supervised preoperative exercise programs are rarely offered in routine care. Telehealth-delivered exercise programs offer a promising solution, but evidence of their feasibility, acceptability, and impact in the MBS setting remains limited. OBJECTIVE This study (BARI-Prehab) aims to assess the efficacy and acceptability of a telehealth-delivered prehabilitation exercise program in improving cardiometabolic health among patients awaiting MBS. METHODS In this multicenter, open-label, randomized controlled trial, we will randomize 48 adult participants (1:1) to either usual care (control group) or a 4-week telehealth exercise intervention. The primary outcome is aerobic capacity (VO2 in mL/kg/min at the anaerobic threshold), measured using cardiopulmonary exercise testing. Secondary outcomes include resting heart rate, heart rate variability, resting metabolic rate, body composition, grip strength, and 7-day physical activity. Intervention acceptability will also be evaluated. RESULTS Data collection and analysis are ongoing. This trial, funded in September 2020, will evaluate the capacity of a telehealth exercise program to improve cardiometabolic health and determine its suitability for implementation in the MBS preoperative pathway. Following initial protocol development, ethics approval, and trial setup, the clinical phase formally commenced with registration on June 16, 2023. Enrollment is ongoing, with a projected end date of March 2026. As of May 2025, a total of 220 patients have been screened for participation, of whom 30 have enrolled in the trial. The first results are expected to be submitted for publication by mid-2026. CONCLUSIONS The BARI-Prehab trial will provide evidence on the acceptability and impact of a remotely delivered exercise intervention in the context of MBS. These findings will have implications for the design of accessible, scalable preoperative care models. The significance of this research lies in its potential to guide clinical practice, inform policy, and improve health outcomes for patients undergoing MBS. CLINICALTRIAL ClinicalTrials.gov NCT05235945; https://clinicaltrials.gov/study/NCT05235945 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/77538

2 May 2024 in JMIR Preprints
Verified
Preprint
Open access
Duvern RamiahDuvern Ramiah
Duvern Ramiah
SNSonwabile Ngcezu
Sonwabile Ngcezu
OAOluwatosin Ayeni
Oluwatosin Ayeni
OAOkechinyere Achilonu
Okechinyere Achilonu
MAMariam Adeleke
Mariam Adeleke
DMDaniel Mmereki
Daniel Mmereki
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Access to timely radiotherapy in resource-constrained environments, particularly low- and middle-income countries (LMIC), is hampered by infrastructure constraints, workforce shortages, and a rising cancer burden. Remote radiotherapy planning (treatment planning as a service [TPaaS]) has the potential to enhance workflow efficiency, reduce wait times, and expand access to treatment. However, its integration and feasibility in LMIC public health systems remain underexplored. Objective: This study evaluates the feasibility and initial effectiveness of remote radiotherapy planning using the Varian Eclipse system integrated with Elekta Versa HD linear accelerators (LINACs) at the busiest public hospital in South Africa. The primary goal is to determine whether remote planning can maintain plan quality while enhancing efficiency and minimizing treatment delays. Methods: A prospective, single-site, pilot study is being conducted at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in 2 phases. Phase 1 (feasibility) encompasses system commissioning, including beam modeling, computed tomography (CT)-to-electron density calibration, multileaf collimator (MLC) optimization, and dose calculations using the anisotropic analytical algorithm. System performance is validated through gamma index analysis (≥95% pass at 3%/3 mm). Interoperability and workflow readiness are assessed using simulated clinical scenarios and time integration steps. Phase 2 (effectiveness/impact) evaluates operational outcomes in 100 screened adult patients (≥18 years) with cervical, breast, prostate, head and neck, or rectal cancers requiring curative radiotherapy. Patients are grouped by cancer type (25 per group). Time to treatment, plan quality, and system efficiency will be compared with historical in-person planning data. Key workflow metrics include dates of first consultation, CT simulation, planning initiation, plan approval, quality assurance, and treatment start and completion. Results: The study commenced enrollment in November 2023, with completion anticipated by mid-2025. As of July 2024, approximately 44 patients were screened and are anticipated to complete the remote planning. Initial findings show successful MLC transmission and dosimetric leaf gap optimization through iterative testing. Gamma pass rates exceeded 90% on both clinical and test servers, demonstrating initial accuracy. Results, including planning timelines, quality assurance outcomes, and system performance, will be available following comprehensive analysis in the third quarter of 2025. Preliminary findings indicate effective integration of remote planning in a resource-constrained public health sector setting. Conclusions: This study shows that remote radiotherapy planning is feasible and might improve cancer treatment in LMIC. The integration of commercially available systems, such as TPaaS, was successfully achieved without compromising dosimetric quality and ensured workflow continuity. Remote planning could serve as an effective tool to reduce treatment delays and enhance resource utilization in oncology units facing high demand. These findings offer valuable insights into technical integration, quality planning, and workflow outcomes, which can inform the future implementation of effective strategies in resource-constrained settings.

13 November 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
BDBelinda Jayne Durey
Belinda Jayne Durey
Alison M. CoatesAlison M. Coates
Alison M. Coates
KDKade Davison
Kade Davison
BTBrett Tarca
Brett Tarca
JMJessica Mok
Jessica Mok
DMDaniel S Martin
Daniel S Martin
Background: Obesity affects over one billion people globally and is a leading contributor to chronic disease. For those with clinically severe obesity, metabolic and bariatric surgery (MBS) is the most effective intervention for long-term weight loss. However, surgery is often delayed due to systemic barriers, during which time patients may experience further health decline. Low cardiorespiratory fitness is a known risk factor for perioperative complications, prompting recommendations for prehabilitation to target readiness for surgery. Despite this, few patients meet physical activity guidelines, and supervised preoperative exercise programs are rarely offered in routine care. Telehealth-delivered exercise programs offer a promising solution, but evidence of their feasibility, acceptability, and impact in the MBS setting remains limited. Objective: This study (BARI-Prehab) aims to assess the efficacy and acceptability of a telehealth-delivered prehabilitation exercise program in improving cardiometabolic health among patients awaiting MBS. Methods: In this multicenter, open-label, randomized controlled trial, we will randomize 48 adult participants (1:1) to either usual care (control group) or a 4-week telehealth exercise intervention. The primary outcome is aerobic capacity (VO2 in mL/kg/min at the anaerobic threshold), measured using cardiopulmonary exercise testing. Secondary outcomes include resting heart rate, heart rate variability, resting metabolic rate, body composition, grip strength, and 7-day physical activity. Intervention acceptability will also be evaluated. Results: Data collection and analysis are ongoing. This trial, funded in September 2020, will evaluate the capacity of a telehealth exercise program to improve cardiometabolic health and determine its suitability for implementation in the MBS preoperative pathway. Following initial protocol development, ethics approval, and trial setup, the clinical phase formally commenced with registration on June 16, 2023. Enrollment is ongoing, with a projected end date of March 2026. As of May 2025, a total of 220 patients have been screened for participation, of whom 30 have enrolled in the trial. The first results are expected to be submitted for publication by mid-2026. Conclusions: The BARI-Prehab trial will provide evidence on the acceptability and impact of a remotely delivered exercise intervention in the context of MBS. These findings will have implications for the design of accessible, scalable preoperative care models. The significance of this research lies in its potential to guide clinical practice, inform policy, and improve health outcomes for patients undergoing MBS. Trial Registration: ClinicalTrials.gov NCT05235945; https://clinicaltrials.gov/study/NCT05235945 International Registered Report Identifier (IRRID): DERR1-10.2196/77538